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Abstract
The environmental risk assessment of the veterinary pharmaceutical ivermectin is receiving significant attention.
This paper assesses the capacity of the MS·3 soil microcosm as a tool for targeting the environmental impact assessment
of veterinary drugs, using ivermectin as model. Two screening MS·3 were performed using different European soils;
one with a soil collected in an agricultural station near to Madrid, Spain and a second with a soil collected in a farm
area close to York, UK. Soils were fortified with ivermectin at the following ranges: 0.01-10 mg kg–1 and 0.1-100 mg
kg–1 in the Madrid and York studies, respectively. The effects on earthworms, plants and soil microorganisms were
assessed in the Madrid soil. Toxicity tests on aquatic organisms (algae, cladocerans and in vitro fish cell line RTL-
W1) were also conducted with the leachates. No effects were observed in earthworms and plants at any tested
concentration; reduction in the respiration rate (< 5%) of soil microorganisms was detected. Earthworm/soil
bioconcentration factors decreased with the increase in soil concentrations and were higher for the York soil. Effects
on daphnids were observed in tested leachates; based on measured levels of ivermectin in the leachates an EC50 of
about 0.5 µgL–1 can be estimated. Comparisons based on toxicity data and equilibrium partitioning confirmed that the
main risk is expected to be related to the high sensitivity of cladocerans. The results confirm that MS·3 systems are
cost-effective tools for assessing the impact of veterinary pharmaceuticals when applied to agricultural land, as
previously demonstrated for antimicrobials.
Additional key words: effects; ivermectin; higher tier ecotoxicity test; soil microcosm; veterinary medicines.
Resumen
Valoración ambiental de medicamentos veterinarios en suelos agrícolas utilizando sistemas multi-especies
(MS·3): la ivermectina como caso de estudio
La evaluación del riesgo ambiental de la ivermectina recibe atención. Este trabajo considera la capacidad de mi-
crocosmos terrestres (MS·3) para evaluar el impacto de medicamentos veterinarios, utilizando ivermectina como mo-
delo. Se realizaron experimentos en MS·3 con dos suelos europeos, uno de una zona agrícola cercana a Madrid, Es-
paña y otro de una explotación cerca de York, UK. Los suelos fueron fortificados con ivermectina considerando rangos
de 0,01 a 10 mg kg–1 con suelo de Madrid y de 0,1 a 100 mg kg–1 con suelo de York. En el MS·3 de Madrid se evalua-
ron los efectos sobre lombrices, plantas y microorganismos. En los lixiviados, se ensayó la toxicidad en organismos
acuáticos (algas, invertebrados y ensayos in vitro, con líneas celulares de peces RTL-W1). Las lombrices y las plan-
tas no mostraron efecto a las concentraciones consideradas; sí se observó reducción en la tasa de respiración (< 5%)
de microorganismos. Los factores de bioconcentración en lombriz disminuían conforme aumentaba la concentración
de ivermectina en suelo y éstos fueron mayores en lombrices expuestas al suelo de York. Hubo efectos sobre daphni-
dos expuestos a lixiviados; basado en los niveles de ivermectina medidos en lixiviados, se estimó una EC50 de 0,5µg
L–1. La comparación entre datos de toxicidad y métodos de equilibrio de partición confirma que el principal riesgo de
la ivermectina debe esperarse en daphnias debido a la alta sensibilidad de cladóceros. Los resultados confirman que
los MS·3 pueden considerarse una herramienta útil para la evaluación de impacto ambiental de medicamentos veteri-
narios en suelos agrícolas, como ya se demostró previamente con antimicrobianos.
Palabras clave adicionales: efectos; ivermectina; medicamentos veterinarios; microcosmos terrestre; prueba de
ecotoxicidad de alto nivel.
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Introduction
Ivermectin, an avermectin parasiticide of high
environmental concern, is broadly used as endo- and
ecto-antiparasitic drug for treating livestock (Nessel et
al., 1989; Alvinerie et al., 1998; Edwards et al., 2001).
Pharmacokinetic studies demonstrated a moderate
metabolism, and significant amounts of the parent drug
have been found in the dung of several livestock species
(Alvinerie et al., 1998; Fernández et al., 2009). The main
environmental concerns when treating animals with
ivermectin are associated to their dung excretion, re-
presenting a potential risk to dung and soil fauna and
also to aquatic organisms due to runoff losses from
manure or slurry applications (Halley et al., 1989; Van
den Brink et al., 2005). Aquatic organisms, in parti-
cular freshwater crustaceans such as amphipods and
cladocerans, are the most sensitive organisms (Edwards
et al., 2001; Garric et al., 2007). However, the concen-
trations measured in dung can also provoke toxic effects
on terrestrial organisms (Edwards et al., 2001; Jensen
et al., 2003; Floate et al., 2005; Fernández et al., 2009).
During the last two decades, the environmental risk
assessment of veterinary medicines including ivermectin
has received significant attention (Halley et al., 1989;
Van den Brink et al., 2005). The concerns were consi-
dered by regulatory bodies and the International
Cooperation on Harmonization of Technical Require-
ments for Registration of Veterinary Medicinal Pro-
ducts developed specif ic guidance (VICH, 2000,
2004), which have been implemented in the European
Union (EMEA, 2008). Specific provisions are consi-
dered for antiparasitic drugs, due to their high toxicity
for certain taxonomic groups. Regulatory guidance
focus on the use of standardised procedures and assays,
which were originally developed for assessing other
chemical groups; however, pharmaceuticals are desig-
ned for accomplish very precise biological functions,
and are typical example for considering targeted envi-
ronmental risk assessments (Tarazona et al., 2010).
Micro and mesocosms have been considered as a parti-
cularly useful method for targeting the environmental
assessment of pharmaceuticals (Van den Brink et al.,
2005). Veterinary medicines are mostly released into
the agro-sphere, either directly during pasture or when
using manure as agricultural fertilizer. The multi-spe-
cies soil system (MS·3) was developed by our group
as a simplified soil microcosms specifically designed
for assessing effects on agricultural land (Fernández
et al., 2004; Boleas et al., 2005a,b). The system balan-
ces the benefits of standardisation with the needs for
realistic conditions, combining the toxicity endpoints
measured in several OECD guidelines in a cost-effec-
tive assay reproducing realistic agricultural soil condi-
tions. This higher tier ecotoxicity test has been desig-
ned as an artificially assembled soil microcosm where
soil macro-organisms, plants and invertebrates, are
added into a sieved column of natural soil that provides
a complex microbial community. The capability of
MS·3 soil microcosms for addressing the environmen-
tal risk of veterinary pharmaceuticals has been tested
elsewhere (Montforts et al., 2003), and several studies
on antimicrobial drugs have been conducted (Boleas
et al., 2005a,b). This paper assess the capacity of the
MS·3 soil microcosm as a cost-effective screening tool
for targeting the environmental impact assessment of
veterinary drugs. Ivermectin was selected as a case model
as this drug combines a set of remarkable characteristics
governing its biocidal activity and environmental con-
cerns. Ivermectin has a high molecular weight, above
the threshold which for general chemicals is assumed
as indicator of low toxicity due to inability for crossing
cellular membranes (ECB, 2003). It has a low solubi-
lity in water, a log Kow above 3 and it sorbs strongly to
soil, with a soil organic carbon distribution coefficient
(Koc) of 12,600-25,800 (Bloom and Matheson, 1993)
although the presence of cations such as Ca2+ leads to
decreasing soil sorption (Krogh et al., 2008). More-
over, ivermectin has a high acute and chronic toxicity
for several taxonomic groups (Halley et al., 1989) with
cladocerans being extremely sensitive (Garric et al.,
2007). Therefore, the MS·3 ivermectin results com-
plement our previous observations for antimicrobial
drugs.
Material and methods
Characteristics of the soils
MS·3 experiments were made up of two European
loamy sand soils, from the Mediterranean and Atlantic
eco-regions, covering a wide range of organic matter
and nutrient content. The low organic matter Medi-
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Abbreviations used: HLB (hydrophobic liphophylic balance); iv (ivermectin); MS·3 (multi-species-soil-system); SPE (solid phase
extraction).
terranean soil was collected at a research facility loca-
ted 40 km northeast of Madrid, Spain. The high organic
matter Atlantic soil was collected in a farm area close
to York, UK. Both soils were collected in sites not
exposed to ivermectin for at least the last 10 years and,
consequently, background concentrations of ivermec-
tin were below the detection level. The Madrid soil has
been also not treated with pesticides, fertilizers or soil
amendments. This situation could not be confirmed
for the York soil, and some leachate control samples
provoked toxicity in daphnids, thus the York soil was
only used for characterising the environmental fate of
ivermectin. Soil samples were taken within the top
20cm of the soil layer, sieved through a 2 mm mesh
and homogenised before use. Table 1 shows the phy-
sico-chemical characteristics of both soils used in our
MS·3 experiments. These two soils were classified as
loamy sand soils, showing differences in the organic
matter content (0.32% and 2.32% for Madrid and York
soils, respectively) and the pH (8.30 for Madrid soil
and 6.30 for York soil, respectively). These differences
could play an important role in the behaviour (potential
leaching, availability) of contaminants. The ivermectin
soil-water distribution coefficient (Kd) varied from 57
(Madrid soil) to 396 (York soil) L kg–1 (Krogh et al.,
2008).
Multi-species-soil-system (MS·3) design
The MS·3 is an artificial assemblage of soil macro-
organisms (i.e. plants, invertebrates) lying on homoge-
neous columns of sieved natural soil (for a full descrip-
tion see Fernández et al., 2004) allowing combined
assessments of fate and effects. Soil columns were
assembled in PVC cylinders (20 cm internal diameter
and 30 cm high), with a leachate collection device atta-
ched at the bottom of each column. The columns were
maintained in a climate-control room with a 16h light/ 
8 h dark photoperiod (1,200 lux ± 13% CV), tempera-
ture of 21 ± 1°C and humidity of 55-60%.
The MS·3 assess simultaneously fate properties and
the sensitivity of several taxonomic groups under rea-
listic exposure conditions. This study was used as
screening tool, using two largely different soils and
distributing concentrations in orders of magnitude.
Test compound and soil fortification
Ivermectin (CAS Nº. 70288-86-7, purity 94% B1a
and 2.8% B1b) was purchased from Sigma Aldrich. For
this screening assessment, ivermectin concentrations
were assayed in orders of magnitude, ranging from
0.01 to 10 mg iv kg–1 dry wt for (MS·3-A) and 0.1 to
100 mg iv kg–1 dry weight for (MS·3-B). Spring water
was added to all soils until reaching 40% of the maxi-
mum water holding capacity (WHCmax). All MS·3, con-
trols and iv-fortified, were assayed in triplicates.
Soil invertebrates and plants
The selected taxonomic groups used in the MS·3 ex-
periments were terrestrial invertebrates (Eisenia fetida,
Savigny) and mono and dicotyledonous plants. Eisenia
fetida has been cultured for several generations in our
laboratory and certif ied seeds of the vascular plants
wheat Triticum aestivum L, rape Brassica napus L, red
clover Trifolium pratense L and common vetch Vicia
sativa L, were kindly supplied by the Spanish Office
of Plant Varieties. These species are recommended in
OECD Guidelines 207 and 208 (OECD, 1984a,b).
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Table 1. Physico-chemical properties of Madrid and York
soils used in the MS·3 studies
Madrid soil York soil
Moisture (%) 0.50 1.00
pH 8.50 6.30
EC (dS cm–1) 0.16 0.13
Organic matter (%) 0.32 2.65
N-NO3– (mg kg–1) < 1 15
P (mg kg–1) 19 49
K (mg kg–1) 107 56
Mg (mg kg–1) 94 169
CaCO3 equiv. (%) < 4 < 4
Ca (mg kg–1) 3,795 1,191
Na (mg kg–1) 37 46
Sand (0.05 < D < 2 mm) (%) 79 68.80
Silt (0.02 <D < 0.05) (%) 8.80 6
Silt (0.002 < D < 0.02) (%) 6.80 13.30
Clay < 0.002 mm (%) 5.40 11.90
Soil type (USDA) Loamy sand Loamy sand
N-NH3 (mg kg–1) 4.70 8
CEC (meq 100 g–1) 4.70 10
Cu (mg kg–1) 6 27
Fe (mg kg–1) 32 852
Zn (mg kg–1) 21 58
N Kjeldahl (%) 0.04 0.16
WHCmax (%) 21.33 21.93
D: diameter size. CEC: cation exchange capacity. WHCmax: ma-
ximum water holding capacity.
MS·3: experimental protocol
MS·3 systems were saturated with spring water
(750-1,000 mL in each MS·3 column) and left overnight.
Then, groups of 10 E. fetida adults, 10 T. aestivum
seeds, and 10 T. pratense seeds for (MS·3-A), or 10 
V. sativa seeds for (MS·3-B), were introduced in each
column. One hour later, columns were irrigated with
100 mL of spring water. A fixed volume of 100 mL of
spring water was added (from Monday to Friday) and
leachates were collected at days 0, 14 and 21.
Electrical conductivity and pH were measured in
leachates samples at the beginning and on days 7, 14
and 21, using a pH-meter, (Orion 520A, Boston, MA,
USA) and a conductivimeter (Crison, Barcelona, Spain).
Ivermectin analysis
Sample extraction and clean-up procedures were
based on the methodology described by Kolar et al.
(2004), for the determination of abamectine and dora-
mectine in sheep faeces. HPLC analysis followed the
procedure described by Sun et al. (2005). Briefly, the
procedures were as described below.
Ivermectin soil sample extraction and clean-up
procedure
In a 100 mL centrifuge tube, 20g of soil sample were
mixed with 10 g of anhydrous sodium sulphate; after
the addition of 40 mL of acetonitrile containing 50 µL
of triethylamine (Sigma-Aldrich T0886), the mixture
was extracted in an ultrasonic bath for 15 min; the ace-
tonitrile phase was separated by centrifugation (5 min,
3,500 rpm). A volume of 30 mL of the acetonitrile
phase was mixed with 70 mL of MilliQ water before
SPE using HLB cartridges (Strata-X 33 µm 60 mg/
3 mL, Phenomenex 8B-S100-UBJ), previously activated
with: 5 mL acetonitrile, 5 mL acetonitrile/MilliQ water
30:70 (v:v) and 5 mL water MilliQ. After washing 
(5 mL acetonitrile/MilliQ water 30/70) and drying, iv
was eluted from the SPE cartridge with 5 mL of aceto-
nitrile. Then, 0.2 mL of internal standard acetonitrile
solution (200 ng mL–1 abamectin 46392 PESTANAL,
Riedel-de-Häen) were added to eluate and then evapo-
rated to dry by vacuum using a Genevac EZ-2 evapora-
tion system at its maximum temperature (30°C). After
drying, the residue was derivatized with 1-methylimi-
dazol following the procedure according to Sun et al.
(2005).
Ivermectin leachate sample extraction and clean-up
procedure
A volume of 50 mL leachate was mixed with 50 µL
triethylamine and 20 mL acetonitrile. Thereafter, SPE
were performed using HLB cartridges (Strata-X 33 µm
60 mg/3 mL, Phenomenex 8B-S100-UBJ) with the
same procedure used for soil samples.
Ivermectin earthworm sample extraction and clean-up
procedure
In a 50 mL glass vessel, a pool of 10 earthworms
(from each MS·3 column) were weighed. Acetonitrile
(50 mL) and 50 µL of triethylamine were added before
homogenization (IKA T25 digital ULTRA-TURRAX).
After washing with another 20 mL of acetonitrile, the
slurry was centrifuged (3,500 rpm, 5 min). Acetonitrile
extract (30 mL) were f iltered (Sartorius glasf ibre
filter) and diluted with 70 mL of MilliQ water. Then
SPE was performed using HLB cartridges (Strata-X33
µm 60 mg: 3 ml, Phenomenex 8B-S100-UBJ) with the
same procedure used in soil samples.
Validation and calibration curves
Methods for soil and leachate were validated using
iv-fortified (soil and leachate) control samples. Cali-
bration curves were prepared daily using fortified sam-
ples, prepared by adding iv acetonitrile solution in
order to obtain standard samples containing iv concen-
trations ranging from 0.0025 to 0.05 ng mL–1 in lea-
chates samples and from 0.0625 to 2.5 ng g–1 wet weight
in soil samples. Standard samples were extracted in
parallel with unknown samples. The method for earth-
worms was not validated.
Ivermectin HPLC analysis
A volume of 100 µL of standard or sample solution
was injected in a HPLC system equipped with Waters
2695 Separations Module, Waters 2475 Fluorescence
detector and Millennium 32 chromatographic software.
The chromatographic conditions used were the follow-
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ing: Column Luna 5 µm C18 (2), 250 × 4.60 mm (Phe-
nomenex) at 40°C, mobile phase: MilliQ water: aceto-
nitrile 3:97 at 1.5 mL min–1 and fluorescence detection
at 365 nm (Ex) and 475 nm (Em). Quantitation was
performed by internal standard procedure.
Recoveries, limits of detection and quantization
The percentage of recovery was determined on 
4 samples (50 mL) of control laeachate fortified with
2 µg L–1 (96% ± 2%) and on 3 samples (15 g) of control
soil spiked at 10 µg kg–1 (91.5% ± 2.09%) and 50 µg
kg–1 (85% ± 3%). Following the above described sam-
ple preparations, detection limits were 0.02 ng mL–1
and 0.10 ng g–1 for leachate and soil samples, respec-
tively. Quantifications limits were established at the
lowest calibration point and detection limit were esta-
blished at 2.5 times below the quantization limit, with
a signal/noise ratio higher than 10.
Ecotoxicological effects assessment
Effects on plants (seed germination) and earthworms
(mortality) were determined in the Madrid soil at the
end of the 21 exposure days.
Soil microbial function effects were determined by
measuring soil enzymatic dehydrogenase and phospha-
tase (Carbonell et al., 2000) activities, and substrate
induced respiration rate (Fernández et al., 2004).
Measurements were conducted at three depths of the
soil column (top, medium and bottom). Respiration
rate was analyzed according to the procedure described
by Fernández et al. (2004). The effect of iv on soil mi-
crobial respiration, measured as glucose-induced CO2
production rate, was determined at 22°C using BacTrac
4300 system (SY-LAB, GmbH, P.O. Box 47, A-3002
Purkersdorf, Austria); the methodology is based on the
variation of conductivity of a 0.2% KOH water solu-
tion. Respiration rates were calculated in the linear
phase of the respiration curves.
Using leachates, indirect effects on aquatic orga-
nisms were assessed. Daphnia acute immobilisation
test (OECD guideline 202; OECD, 2004), alga growth
inhibition test (OECD guideline 201; OECD, 2002)
and in vitro toxicity test on fish cell line RTL-W1 (Babin
and Tarazona, 2005) were performed.
The Daphnia magna immobilisation test was con-
ducted for each leachate in duplicate, in a thermos-
tatised chamber (20 ± 1°C) with 16 h light/8 h dark
photoperiod. Leachates from untreated MS·3 were
carried out in parallel as controls; 10 daphnids (< 24 h-
old) were exposed directly in leachate (15 mL) and
48 h later, daphnids unable to swim for 15 s after gentle
stirring were considered as immobile. The EC50 48 h
was calculated (µg L–1) based on the measured concen-
tration of iv in the leachates.
The unicellular green algae (Chlorella vulgaris)
growth inhibition tests were conducted following the
adaptation of the freshwater algae and cyanobacteria,
growth inhibition test, guideline 201 (OECD, 2002),
using 96-well microplates (Ramos et al., 1996). This
method evaluates the algal growth using 96-well
microplates by absorbance (450 nm) and/or fluoresc-
ence (430 Ex/680 Em) multiwell plate reader (TECAN-
Genius spectrofluorometer); when interference of
effluent samples with absorbance and/or fluorescence
determination was detected, microscopic counts on
aliquots of each treatment were performed. The use of
alternative in vitro methods represents a possibility for
assessing the effects of chemicals (Worth and Balls,
2002). In vitro toxicity tests on fish cell line RTL-W1
were performed with leachates; EROD activity, 
β-galactosidase activity and cellular viability (neu-
tral red assay) were analyzed following the proce-
dures described in Babín and Tarazona (2005), with
leachates reconstituted with 10x EMEM media. The
use of a concentrated media diluted directly with the
sample to be tested allowed the exposure of cell
cultures to concentrations around 75% of the original
sample. Water controls (water reconstituted 10x
EMEM media) were run in parallel. In addition, total
protein content of the cells was measured using the
Kenacid blue protein (KBP) assay (Knox et al., 1986).
The presence of organic toxic chemicals was indicated
by the induction or inhibition of the cytochrome
CYP1A activity measured as 7-ethoxyresoruf in-O-
deethylase (EROD) activity (Babin and Tarazona,
2005), cellular defense was predicted by a β-galac-
tosidase (β-GAL) assay (Babín and Tarazona, 2005).
To quantify fluorescence (kinetic way) and absorbance
endpoints, a TECAN-Genius spectrofluorometer was
used.
Statistical analysis
Statistical differences associated to the iv treatment
were analysed by one-way ANOVA test and least signi-
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f icant differences multiple range test. EC50 values
were estimated by probit analysis. All statistic estima-
tions were conducted using the Statgraphics Plus Ver.
5.1 software.
Results
Chemical properties of leachates
Volume, pH and electrical conductivity of collec-
ted leachates are summarized in Table 2. The pH va-
lues were kept constant during the exposure time and
no significant differences between control and treat-
ments were observed. In general, leachates from
(MS·3-B) showed higher EC values than leachates
from (MS·3-A).
Ivermectin analysis in MS·3 soil 
and leachates
The initial iv concentrations measured in fortified
soils were: 0.008 ± 0.003; 0.079 ± 0.020; 0.630 ± 0.319
and 5.71 ± 4.47 mg kg–1 dry weight for (MS·3-A) and
0.204 ± 0.004; 1.198 ± 0.017; 12.965 ± 0.088 and
106.695 ± 5.542 mg kg–1 dry weight for (MS·3-B).
Table 2 shows the iv concentration in the collected lea-
chates at different times. Ivermectin was not detected
(LD = 0.020 ng L–1) in leachates from the lowest con-
centration (0.01 mg kg–1 dry weight); but most other
samples showed detectable concentrations. Concentra-
tions were mostly related to the soil nominal concen-
tration; and in general, leachates from Madrid soil
tended to be have higher concentrations than leachates
from York soil; however, very high concentrations were
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Table 2. Chemical analysis of leachates from Madrid (MSD·3-A) and York (MS·3-B) leachates
Ivemectin concentration in (MS·3-A) leachates: mean ± standard deviation
Madrid leachates Date (d) (Variation coefficient)
Control 0.01 mg kg–1 soil 0.1 mg kg–1 soil 1 mg kg–1 soil 10 mg kg–1 soil
Volume (mL) (0,7,14,21) 137.42 ± 63.06 125.38 ± 60.69 103.08 ± 62.69 86.50 ± 62.68 52.58 ± 60.74
(45.89) (48.40) (48.40) (72.46) (115.52)
pH (0,7,14,21) 8.26 ± 0.22 8.36 ± 0.18 8.36 ± 0.17 8.36 ± 0.20 8.28 ± 0.21
(2.64) (2.19) (2.01) (2.42) (2.48)
EC (µS cm–1) (0,7,14,21) 1,109 ± 103.20 1,110 ± 90.51 1,074 ± 91.81 1,200 ± 168.07 1,216 ± 277.59
(9.31) (8.22) (8.55) (13.99) (22.83)
Iv (ng mL–1) 0 ND ND ND 2.7* 23.3**
7 ND ND 1.2** 2.2** 46.1*
14 ND ND ND 1.2 ± 0.3 20.4*
Ivemectin concentration in (MS·3-B) leachates: mean ± standard deviation
York leachates Date (d) (Variation coefficient)
Control 0.1 mg kg–1 soil 1 mg kg–1 soil 10 mg kg–1 soil 100 mg kg–1 soil
Volume (mL) (0,7,14,21) 177.17 ± 89.89 190.08 ± 115.83 201.33 ± 115.72 163.08 ± 103.17 133 ± 75.84
(50.70) (60.94) (57.48) (63.26) (57.02)
pH (0,7,14,21) 7.16 ± 0.33 7.63 ± 0.70 7.25 ± 0.66 7.18 ± 0.50 6.93 ± 0.22
(4.56) (9.19) (9.12) (7) (3.11)
EC (µS cm–1) (0,7,14,21) 1,496 ± 250 1,456 ± 350 1,497 ± 400 1,490 ± 349 1,184 ± 269
(16.69) (24.02) (26.70) (24.77) (22.72)
Iv (ng mL–1)
0 ND 0.02 ± 0.04 ND 0.195 ± 0.190 ND
7 ND ND ND 1.04 ± 0.41 3.15 ± 1.76
14 ND 4.21 ± 0.37 14.07 ± 24.17 4.96 ± 3.13 8.47 ± 7.69
21 ND 0.27 ± 0.36 0.30 ± 0.33 0.28 ± 0.49 1.84 ± 2.97
ND < LD = 0.02 ng mL–1. *: One value. **: Mean of two values.
observed in the leachates from the York soil treated with
0.1 and 1 mg kg–1. A similar pattern was observed for
both soils, with leachate concentrations peaking at day
14 for the York experiment in all treatments and at diffe-
rent days in different treatments for the Madrid study.
Ivermectin effects on terrestrial invertebrates,
plants and microorganisms in MS·3
The effect on earthworms, plants, and microorganisms
observed in the Madrid soil are shown in Table 3. Only
soil microbial functions were affected, mostly at the
highest iv concentration tested. Slightly reductions in
the respiration rate (< 5%) were observed at the be-
ginning of the exposure but were not longer observed
at day 21.
Ivermectin concentrations in Eisenia fetida after 21
exposure days are shown in Figure 1.
A direct relationship between soil and earthworm
concentrations was observed; however, a non-linear
inverse relationship was observed for the earthworm-
soil bioaccumulation factors, which are presented in
Figure 2. It should be noticed that the earthworm/soil
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Table 3. Endpoints and results of a multi-species soil system (MS·3) assay with ivermectin
Endpoint Time (d) Control
Dose (mg Iv kg–1 soil)
0.01 0.1 1 10
E. fetida mortality (%) 21 0 0 0 0 0
Seed germination (%) 21 T. aestivum 93 97 93 90 93
V. sativa 93 97 100 90 97
Soil dehydrogenase (%) 0 NS NS NS NS
21 Top NS NS NS 42.02 ± 6.55a
(–34.63) 
Medium NS NS NS NS
Bottom NS NS NS NS
Soil phosphatase (%) 0 NS NS NS NS
21 Top NS NS NS 37.61 ± 2.53a
(–9.47%)
Medium 22.09 ± 2.21a NS NS 22.33 ± 2.28a
(–20.17%) (–19.42%)
Bottom NS NS NS 39.46 ± 4.75a
(–11.27%)
Respiration rate (%) 0 NS 1.10 ± 0.04a 1.07 ± 0.04a 1.07 ± 0.05a
(–2.30%) (–4.96%) (–5.01%)
21 Top NS NS NS NS
Medium NS NS NS NS
Bottom NS NS NS NS
a Statistically signif icant differences for the iv soil concentration in the one-way ANOVA test (p < 0.05). NS: not signif icant. 
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Figure 1. Ivermectin concentration in Eisenia fetida collected after exposure in MS·3 experiments from Madrid (MS·3-A) and
York (MS·3-B) soils.
bioaccumulation factors were higher for the York than
for the Madrid soil.
Ivermectin effects on aquatic organisms
Effects on Daphnia magna immobilisation was
observed in the leachates. Figure 3 shows the concent-
ration/response relationship based on measured levels
of iv in the leachates; an EC50 about 0.5 µg L–1 was
estimated. Concentrations at and above 1 µg L–1 re-
sulted in a 100% immobilisation. It should be noted
that this concentration was exceeded at least at one
time point in the leachates from all soils treated with
iv concentrations of 0.1 mg kg–1 or higher. On the other
hand, algae and the RTL-W1 fish cell line did not seem
to be affected by iv at the concentrations assayed.
Daphnia magna immobilisation was the most sensitive
endpoint.
Discussion
The early identification of the most relevant recep-
tors in an environmental risk assessment may avoid
unnecessary testing focusing the resources on those
receptors representing the highest level of risk. Within
the frame of the ERAPharm project several ways for
targeting the environmental risk of pharmaceuticals
have been proposed (Tarazona et al., 2010). One possi-
bility is described as the risk line approach. The risk
line represents a further development of the exposure
scenario concept; each line connects each environmen-
tal release with each relevant ecological receptor,
sorting out all the processes associated to the exposure
of that particular receptor. Screening tools can be used
to identify the relevance of each risk line, prioritizing
further refinements if needed. The default conditions
established for setting generic scenarios and equili-
brium partitioning methods adapted to the characte-
ristics of the substance can be used for preliminary
comparisons among organisms exposed through
different media (e.g. water, sediment or soil). The MS·3
microcosm also offers some comparative assessments
by measuring simultaneously the toxicity of a soil and
their leachates obtained under realistic conditions to
soil organisms and aquatic species respectively.
The toxicity of iv to aquatic organisms is characte-
rized by a huge divergence in sensitivity among species.
Cladocerans are one-to-two, three and five orders of
magnitude more sensitive than other crustaceans, fish
and mollusks, respectively (Halley et al., 1989; Davies
et al., 1997; Garric et al., 2007). However, this diver-
sity is not observed for soil dwelling invertebrates.
Collembolans are just one order of magnitude more
sensitive than earthworms and enchytraeids (Halley et
al., 1989; Gunn and Sadd, 1994; Römbke et al., 2010).
The acute to chronic ratio is also much higher for cla-
docerans (four orders of magnitude according to Garric
et al. (2007) than for soil invertebrates such as collem-
bolan and earthworms (Halley et al., 1989; Gunn and
Sadd, 1994; Jensen et al., 2003; Römbke et al., 2010).
The equilibrium partitioning method is used for extra-
polating aquatic toxicity data to the soil compartment
(Bockting et al., 1993). Using the iv Koc range and the
default values recommended in the EU guidelines
(ECB, 2003; ECHA, 2008), the acute and chronic































Figure 2. Relationship between ivermectin soil concentration
and earthworm/soil bioconcentration factors in Eisenia fetida
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Figure 3. Concentration response relationship between the me-
asured ivermectin concentration in the Madrid soil leachates
and the observed immobilisation in Daphnia magna (fitting ad-
justment and 95% confidence intervals).
toxicity data available for aquatic species (Halley et
al., 1989; Davies et al., 1997; Garric et al., 2007) can
be compared with those observed for soil dwelling or-
ganisms (Halley et al., 1989; Gunn and Sadd, 1994;
Jensen et al., 2003; Römbke et al., 2010). Based on
the data published by Garric et al. (2007), cladocerans
would be about three and six orders or magnitude more
sensitive that soil organisms for acute and chronic
effects, respectively. However, other crustaceans and
f ish would be just slightly more sensitive than soil
invertebrates. The screening MS·3 is consistent with
this assessment, and offers the same information with
a single cost-effective test. The additional advantage
is that the comparison is not based on soil pore water
equilibrium partitioning but on direct toxicity testing
of soil leachates obtained under realistic environmental
conditions. The leachates are toxic to cladocerans at
concentrations at least two orders of magnitude below
those toxic for terrestrial plants and earthworms.
The comparison of the EC50 for Daphnia magna ob-
served in the leachates tests (about 0.5 µg L–1) with the
reported values in standardized test (5.7 to 25 ng L–1)
by Garric et al. (2007), suggests that only about 1-5%
of the iv present in the leachate would be bioavailable.
The formation of colloids and complexes with inor-
ganic matter may explain this low bioavailability
(Krogh et al., 2008). It should be noted that when the
leachate concentrations are corrected by the bioavaila-
bility factor calculated for Daphnia magna, the re-
sulting concentrations are lower than those expected
to be toxic for fish, and therefore would explain the
lack of toxicity observed for the RTl-W1 fish cell line.
The lack of effects on algae can be also explained by
the low sensitivity of this taxonomic group to algae
(Halley et al., 1989). A soil sorption mechanism diffe-
rent from lipophylicity would also explain the higher
concentrations observed in the York versus the Madrid
leachates at concentrations of 1 mg kg–1 soil or lower,
despite the much higher organic matter content of the
York soil. The contribution of calcium as a factor
enhancing iv mobility in soil, hypothesized by the same
authors, would suggest higher concentrations in the
Madrid leachates, but this was only observed at con-
centrations of 10 mg kg–1 and higher. Concentration
related tendencies were also observed for earthworm
bioaccumulation. A higher bioconcentration was obser-
ved for the York soil at all tested concentrations. The
comparison of the measured earthworm concentrations
with the NOEL of 0.1 mg kg–1 bw–1 for maternal-toxi-
city effects in a mouse teratogenicity study selected by
the Joint FAO/WHO Expert Committee on Food Addi-
tives (JECFA) and EMEA 2004, suggest concern for
secondary poisoning of terrestrial wildlife even at the
lowest soil concentrations. These results confirm with
real data the recent assumptions from De Lange et al.
(2009) based on expert judgment and multicriteria
analysis. The screening MS·3 soil microcosm would
target the environmental impact assessment of iver-
mectin to the following risk-lines (for details, see
Tarazona et al., 2010): 1) Release to agricultural soil
→ runoff/leaching/drainage to aquatic bodies → risk
to aquatic invertebrates. 2) Release to agricultural soil
→ accumulation into soil dwelling invertebrates →
risk of secondary poisoning to terrestrial wildlife.
The assessment of the extensive amount of infor-
mation available for iv demonstrates that in fact these
are the most relevant risk (Liebig et al., 2010), confir-
ming the capacity of the MS·3 microcosms as screening
tool. It should be noted that the potential risk for dung
fauna is not covered in this assessment. The main limi-
tations of the MS·3 system to be used for pharma-
ceuticals and other chemicals with specific mechanisms
of action, is the use of acute instead of chronic end-
points. Although our group is trying to incorporate
chronic endpoints into the system, a reproducible and
cost-effective assemblage has not been obtained yet.
These limitations can be solved through the combi-
nation of the MS·3 with reproduction assays on daph-
nids and collembolans. It should be noted this test
battery should still be highly cost-effective for targe-
ting the environmental assessment of pharmaceuticals
and other chemicals. The results of the MS·3 pre-
sented here, combined with the single species la-
boratory studies conducted by other ERAPharm 
partners on daphnids (Halley et al., 1989) and collem-
bolans (Römbke et al., 2010) offer suff icient infor-
mation for a targeted assessment of this antipara-
sitic drug, as alternative to a full environmental
assessment also provided by the project (Liebig et al.,
2010). These results are in line with those previously
published for antimicrobials, confirming that MS·3
systems are cost-effective tools for assessing the impact
assessment of veterinary pharmaceuticals in agricul-
tural land.
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